← All stocks

ResMed|

RMD Scheduled selling only

CIK 0000943819 #393 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$1.34M

$227.69K on a plan · $1.11M straight out of an exercise

Sold at will

$0.00

0 of 2 sales

Net

−$1.34M

$0.00 against sales at will

By person

16 insiders · 2 transactions

85.8×

Michael Farrell holds 85.8 times base salary in stock. $104.18M of shares against $1.21M in salary for 2025.

Salary from the company's own proxy. The shares are what Michael Farrell last reported holding, valued at $222.44, the price ResMed Common Stock was last bought or sold at on the open market here, on 8 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Farrell Michael J.

Chairman and CEO

—

$1.11M (1) scheduled

−$1.11M

468,346

0.3247%

$104.18M

0.0%

FARRELL PETER C

Director

—

$227.69K (1) scheduled

−$227.69K

51,803

0.0359%

$11.52M

−40.6%

Sandercock Brett

Chief Financial Officer

—

83,495

0.0579%

$18.57M

−13.9%

Leong Justin

Chief Product Officer

—

29,028

0.0201%

$6.46M

+4.1%

TAYLOR RONALD R

Director

—

24,771

0.0172%

$5.51M

+9.5%

Ghoshal Kaushik

Chief Commercial Officer, SaaS

—

19,353

0.0134%

$4.30M

−11.3%

SULPIZIO RICHARD

Director

—

17,796

0.0123%

$3.96M

+6.5%

Gill Harjit

Director

—

10,940

0.0076%

$2.43M

+22.2%

Drexler Karen

Director

—

10,602

0.0073%

$2.36M

+25.5%

Rider Michael J

Global General Counsel

—

9,488

0.0066%

$2.11M

−11.5%

Tan Desney

Director

—

6,002

0.0042%

$1.34M

+56.1%

Hernandez John

Director

—

5,118

0.0035%

$1.14M

+72.8%

De Witte Jan

Director

—

4,261

0.0030%

$947.81K

−43.3%

DelOrefice Christopher

Director

—

2,423

0.0017%

$538.97K

+807.5%

Burt Carol

Director

—

2,156

0.0015%

$479.58K

—

Mowad-Nassar Nicole

Director

—

777

0.0005%

$172.83K

—

ResMed|

By person

Individual transactions

What was left out